Abstract
A recent paper published in Nature reports that the immunosuppressive activity of tumor-associated macrophages is regulated via PI3K? signaling. Small-molecule inhibitors targeting PI3K? stimulate T cell activity against tumor alone and add additional effects for clinically proven PD1 immunotherapy.
| Original language | English |
|---|---|
| Pages (from-to) | 1267-1268 |
| Number of pages | 2 |
| Journal | Cell Research |
| Volume | 26 |
| Issue number | 12 |
| DOIs | |
| State | Published - 1 Dec 2016 |
| Externally published | Yes |